UPDATE: Emergent BioSolutions says FDA has accepted its anthrax vaccine candidate for review

Canada News News

UPDATE: Emergent BioSolutions says FDA has accepted its anthrax vaccine candidate for review
Canada Latest News,Canada Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

Emergent BioSolutions says FDA has accepted its anthrax vaccine candidate for review

Emergent BioSolutions Inc. said Friday the U.S. Food and Drug Administration has accepted for review its application for approval of its anthrax vaccine. Dubbed AV7909, the vaccine is aimed at people aged 18 through 65 years who have been exposed to anthrax for use along with recommended antibacterial drugs. A decision is expected by April of 2023.

Dubbed AV7909, the vaccine is aimed at people aged 18 through 65 years who have been exposed to anthrax for use along with recommended antibacterial drugs. A decision is expected by April of 2023.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA bans sale of Juul e-cigarettes, citing rise in youth vapingFDA bans sale of Juul e-cigarettes, citing rise in youth vapingThe company's paperwork “lacked sufficient evidence” that the devices can protect public health, the FDA says.
Read more »

CDC panel: Elderly Americans should get newer, souped-up flu vaccinesCDC panel: Elderly Americans should get newer, souped-up flu vaccinesA federal advisory panel says Americans 65 and older should get newer, souped-up flu vaccines.
Read more »

CDC panel recommends US seniors get souped-up flu vaccinesCDC panel recommends US seniors get souped-up flu vaccinesThe panel unanimously recommended certain flu vaccines that might offer more or longer protection for seniors, whose weakened immune systems don’t respond as well to traditional shots.
Read more »

FDA investigates new report of another baby’s death possibly tied to Abbott formulaFDA investigates new report of another baby’s death possibly tied to Abbott formulaThe FDA has reviewed dozens of complaints involving Abbott formula after the company voluntarily recalled its products in February.
Read more »

Moderna Asks FDA to Authorize Variant-Specific COVID VaccineModerna Asks FDA to Authorize Variant-Specific COVID VaccineModerna released study results today showing its new Omicron-specific booster increased antibodies against the coronavirus by a factor of 5, even against some of the newer and more worrisome variants.
Read more »

Dyson Airwrap next generation review – the updated hair styling tool is easier to useDyson Airwrap next generation review – the updated hair styling tool is easier to useWe tried the Dyson Airwrap next generation and it’s definitely an improvement
Read more »



Render Time: 2025-03-09 20:04:18